RBC
JNJ icon

Roble Belko & Company’s Johnson & Johnson JNJ Stock Holding History

Roble Belko & Company’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$901K Hold
3,549
– – 0.1% 65
2026
Q1 		$868K Hold
3,549
– – 0.11% 61
2025
Q4 		$734K Hold
3,549
– – 0.1% 64
2025
Q3 		$658K Buy
3,549
+859
+32% +$147K 0.09% 71
2025
Q2 		$411K Sell
2,690
-30
-1% -$4.61K 0.06% 83
2025
Q1 		$451K Sell
2,720
-743
-21% -$116K 0.07% 78
2024
Q4 		$501K Buy
3,463
+225
+7% +$34.9K 0.08% 75
2024
Q3 		$525K Buy
3,238
+4
+0.1% +$637 0.08% 71
2024
Q2 		$473K Hold
3,234
– – 0.08% 74
2024
Q1 		$512K Hold
3,234
– – 0.09% 72
2023
Q4 		$507K Buy
3,234
+1,572
+95% +$241K 0.1% 61
2023
Q3 		$259K Sell
1,662
-56
-3% -$9.24K 0.05% 78
2023
Q2 		$284K Hold
1,718
– – 0.06% 73
2023
Q1 		$266K Sell
1,718
-30
-2% -$4.84K 0.05% 80
2022
Q4 		$309K Buy
1,748
+418
+31% +$72.2K 0.07% 78
2022
Q3 		$217K Hold
1,330
– – 0.05% 87
2022
Q2 		$236K Sell
1,330
-100
-7% -$17.8K 0.05% 84
2022
Q1 		$253K Sell
1,430
-200
-12% -$34K 0.05% 86
2021
Q4 		$279K Buy
+1,630
New +$267K 0.05% 81
2021
Q3 		– Sell
-1,530
Closed -$252K – 336
2021
Q2 		$252K Hold
1,530
– – 0.06% 85
2021
Q1 		$251K Buy
1,530
+800
+110% +$129K 0.06% 82
2020
Q4 		$115K Hold
730
– – 0.03% 106
2020
Q3 		$109K Sell
730
-2,032
-74% -$301K 0.03% 106
2020
Q2 		$388K Buy
2,762
+208
+8% +$30.3K 0.12% 54
2020
Q1 		$335K Hold
2,554
– – 0.11% 61
2019
Q4 		$373K Hold
2,554
– – 0.1% 64
2019
Q3 		$330K Hold
2,554
– – 0.1% 62
2019
Q2 		$356K Buy
2,554
+1,533
+150% +$212K 0.11% 55
2019
Q1 		$143K Hold
1,021
– – 0.05% 85
2018
Q4 		$132K Hold
1,021
– – 0.05% 85
2018
Q3 		$141K Hold
1,021
– – 0.05% 69
2018
Q2 		$124K Sell
1,021
-295
-22% -$36.8K 0.05% 71
2018
Q1 		$169K Buy
1,316
+152
+13% +$20.5K 0.07% 68
2017
Q4 		$163K Buy
1,164
+435
+60% +$60.6K 0.07% 63
2017
Q3 		$95K Buy
729
+53
+8% +$7.03K 0.04% 74
2017
Q2 		$89K Buy
676
+17
+3% +$2.17K 0.04% 75
2017
Q1 		$82K Sell
659
-350
-35% -$41.8K 0.04% 78
2016
Q4 		$116K Sell
1,009
-859
-46% -$99.2K 0.06% 66
2016
Q3 		$221K Buy
1,868
+78
+4% +$9.46K 0.12% 48
2016
Q2 		$217K Buy
1,790
+905
+102% +$103K 0.12% 49
2016
Q1 		$96K Buy
885
+100
+13% +$10.4K 0.05% 69
2015
Q4 		$81K Buy
785
+75
+11% +$7.54K 0.05% 66
2015
Q3 		$66K Hold
710
– – 0.04% 79
2015
Q2 		$69K Hold
710
– – 0.04% 84
2015
Q1 		$71K Buy
+710
New +$72.2K 0.04% 79

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Roble Belko & Company's JNJ Position: Q2 2026 in Review

Roble Belko & Company held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 3,549 shares worth $901K. The position accounts for 0.1% of the portfolio, ranked #65.

Roble Belko & Company first reported a position in JNJ in Q1 2015 and has held it in 45 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Roble Belko & Company held 3,549 shares of Johnson & Johnson worth $901K as of Q2 2026.
  • Roble Belko & Company left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.1% of Roble Belko & Company's portfolio in Q2 2026, its #65 holding.
  • Roble Belko & Company first reported a position in Johnson & Johnson in Q1 2015 and has held it in 45 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.